Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Phase Scientific
company
About
Phase Scientific provides tool for health care industry.
- 101 - 250
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $749.83K
- Industries
- Bioinformatics,Biotechnology,Health Care
- Founded date
- Jan 1, 2015
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Phase Scientific is a biotech firm that creates diagnostic and data tools to help healthcare providers and patients. They provide tools for cancer, oncology, nipt, molecular diagnostics, NGS, dd PCR, point of care, liquid-phase extraction, sample preparation, purification, enrichment, size selection, cell-free DNA, cfDNA extraction, RNA extraction, viral RNA extraction, DNA methylation, library preparation, and liquid biopsy.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$899.83K
Phase Scientific has raised a total of
$899.83K
in funding over 2 rounds. Their latest funding was raised on
Apr 27, 2017 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 27, 2017 | Grant | $749.83K | 1 |
National Science Foundation
|
— | Detail |
| Dec 15, 2015 | Grant | $150K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
1
Phase Scientific is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
